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Abstract
The foramen of Monro has also been referred to by the name of interventricular
foramen. The structures comprising this foramen are the anterior part of the thala-
mus, the fornix and the choroid plexus. Vital structures surround the foramen, the
damage to which can be catastrophic leading to disability either temporary or
permanent. In the literature it has been shown that tumors occurring in the area
of interventricular foramen are rare and usually cause hydrocephalus. The
operative approach depends upon the location of the tumor which can be either
in the lateral or the third ventricle. Various pathologies which can lead to
foramen of Monro obstruction and obstructive hydrocephalus include colloid cyst,
craniopharyngioma, subependymal giant cell astrocytoma [SEGA], Neurocysti-
cercosis, tuberculous meningitis, pituitary macroadenoma, neurocytoma,
ventriculitis, multiseptate hydrocephalus, intraventricular hemorrhage, function-
ally isolated ventricles, choroid plexus tumors, subependymomas and idiopathic
foramen of monro stenosis. In this chapter, we will discuss the various lesions at the
level of foramen of Monro causing obstructive hydrocephalus and the management
and associated complications of these lesions based on their type, clinical picture
and their appearance on imaging.
Keywords: Foramen of Monro, interventricular foramen, obstruction,
obstructive hydrocephalus, raised intracranial pressure
1. Introduction
The foramen of Monro has also been referred to by the name of interventricular
foramen. The first description of this foramen was given by Alexander Monro in the
year 1783 and 1797. The authors of that era were of the opinion that the use of
nomenclature ‘foramen of monro’ was incorrect; instead ‘interventricular foramen’
would be more apt. Their reason was that Monro had interpreted the connection
between lateral and the third ventricle in an incorrect way.
The structures comprising this foramen are the anterior part of the thalamus, the
fornix and the choroid plexus. Vital structures surround the foramen, the damage to
which can be catastrophic leading to disability either temporary or permanent.
The dimension of this foramen is not even 1 centimeter and thus the area present
for any operative intervention is very small. It is not an easy task for the surgeons to
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excise the lesion as well as safeguard the vital surrounding structures at the
same time.
In the literature it has been shown that tumors occurring in the area of
interventricular foramen are rare and usually cause hydrocephalus. The operative
approach depends upon the location of the tumor which can be either in the lateral
or the third ventricle [1].
In this chapter, we will discuss the various lesions at the level of foramen of
Monro causing obstructive hydrocephalus and the management and associated
complications of these lesions based on their type, clinical picture and their
appearance on imaging.
2. History and anatomy
2.1 Introduction
Fluid balance in central nervous system is basically maintained by cerebrospinal
fluid [CSF], which is derived from blood and secreted by choroid plexus lining
ventricles of the brain. CSF plays a major buoyancy role in the mechanical support
to central nervous system.
Circulation of CSF through ventricular system of cerebral cortex takes place in
such a way that there is free communication between cerebral and spinal subarach-
noid compartment. It start from lateral ventricular cavities passing through fora-
men of Monro, then entering into third ventricle passing down along aqueduct of
Sylvius and reaching fourth ventricle. The exit from fourth ventricle takes place
through foramen of Luschka and foramen of Magendie to subarachnoid space
around brainstem and spinal cord [2].
2.2 History
Foramen of Monro is named after a Scottish physician Alexander Monro
Secundus [1733–1817], he was third son of Alexander Monro Primus and Isabella
MacDonald. He matriculated at Edinburg University in 1745 and received his med-
ical degree in 1755 [3]. He assisted his father Alexander primus in teaching anatomy
who held the chair of anatomy at Edinburg University. Monro Secundus recorded
detailed descriptions and illustrations regarding communication between lateral
and third ventricle of the brain as well as describing changes seen in
hydrocephalus [4].
Monro also made several important observations about cranial cavity with
application of physical principles to the intracranial contents. George Kellie former
student of Monro also studied about blood volume in human brains and reached the
same conclusion as his mentor which is now known as Monro-Kellie hypothesis
which states that the sum of volumes of brain parenchyma, CSF, and intracranial
blood is constant [5].
2.3 Embryology
Central nervous system starts developing from fourth week of intrauterine life.
Neural tube formed shows closure of anterior neuropore by middle of fourth week
and posterior neuropore by end of fourth week. Cranial end of neural tube shows
three dilated brain vesicles as prosencephalon [forebrain], mesencephalon [mid-
brain] and rhombencephalon [hindbrain]. The procesencephalon further subdi-




A] Human embryo, approximately 10.2 mm long, left lateral surface of the diecephlon and telencephalon
removed. B] Human embryo 13.6 mm long, median section. C] Human fetus, approximately 3 months old,
median section showing medial surface of enlarged telencephalon and diencephalon with interventricular
foramen of Monro. [Gray H. THE ANATOMICAL BASIS OF MEDICINE AND SURGERY. 40th ed. Susan
Standring, Elsevier Churchill Livingstone New York; 2008. p.381–383.
Figure 2.
Sagittal section of brain showing following cerebrum, cerebellum and brainstem:A] frontal lobe, B] Paritel lobe,
C] occipital lobe, D] cerebellum, E] corpus callosum, F] septum Pellucidum, G] fornix, H] thalamus, I]
hypothalamus, J] pons, K] midbrain, L] medulla oblongata, black arrow- opening of interventricular foramen
of Monro, yellow star – Interthalamic adhesion, black dotted line – Thalamohypothalamic sulcus.
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lateral ventricle cavities and posterior diencephalon having third ventricle cavity.
The commencement of cerebral diverticula from the wall of forebrain persists as
interventricular foramen of Monro [6]. Ventricular cavities of brain develop in the
neural tube and their enlargement depends of differential growth of the brain
vesicles. Out of the three brain vesicles the cavity of the forebrain gives rise to two
lateral and third ventricles. Lateral ventricle grows as outpouching from the rostral
end of third ventricle and both are interconnected via foramen of Monro (Figure 1).
2.4 Gross anatomy
Foramen of Monro is small slit like communicating channel between paired
lateral ventricle and third ventricle cavity on either side which become clinically
significant when obstructed thus leading to non-communicating hydrocephalus.
Foramen of Monro is located at the junction of roof and anterior wall of lateral
ventricle thus bounded anteriorly by the body and column of fornix and posteriorly
by anterior nucleus of thalamus (Figure 2). Size and shape of the foramen corre-
lates with that of ventricles. In an embryo it is large and circular and as the ventricle
size increases, it narrows into a slit like opening. Not only choroid plexus but
posterior choroidal, superior choroidal arteries, thalamostriate and septal veins also
pass through it (Figure 2).
3. Neuro radiology
See Figure 3.
3.1 Spectrum of foramen of Monro lesions causing obstructive hydrocephalus
(Table 1)
The 3rd ventricle is bounded by the interventricular foramen on either side
where the roof and anterior wall of the third ventricle meet the body of the fornix
along with the column anterior to the foramen. Posteriorly it is related to the
thalamus [anterior pole].
Literature shows that tumors in the vicinity of the foramen are uncommon and
usually cause hydrocephalus. Various pathologies which can lead to foramen of
Monro obstruction and obstructive hydrocephalus include colloid cyst,
craniopharyngioma, subependymal giant cell astrocytoma [SEGA], neurocysti-
cercosis, tuberculous meningitis, pituitary macroadenoma, neurocytoma,
ventriculitis, multiseptate hydrocephalus, intraventricular hemorrhage,
Figure 3.
Normal interventricular foramen and its relations on MRI.
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functionally isolated ventricles, choroid plexus tumors, subependymomas and
idiopathic foramen of Monro stenosis.
4. Colloid cyst
4.1 Introduction
Colloid cysts are rare, congenital, histologically benign tumors which represent
upto 2% of all intracranial neoplasms and correspond to approximately 15–20% of
the intraventricular tumors [7]. They occur most commonly in the 3rd to 5th
decades of life. They are usually solitary and sporadic, although rare examples of
cysts on other locations and familial forms are known. They occur in the posterior
end of the foramen of Monro in the anterior and antero-superior part of the third
ventricle [8].
The colloid cyst is an epithelial lined cyst filled with gelatinous material which
commonly contains mucin, old blood cholesterol and ions and may vary in size from
3 to 40 mm in diameter. However size of the cyst does not appear to be a reliable
predictor of outcome, as death may occur even with smaller lesions [9]. Types of
colloid material seen can be a] greenish liquid b] greenish liquid with cholesterol c]
whitish colloid d] greenish colloid e] mixed.
The precise embryopathogenesis of colloid cyst is poorly understood and still a
topic of debate. Various theories proposed are a] origin from either the diencephalic
vesicle or the persistence of embryonic paraphysis b] derived from neuroepithelium
c] remnant of respiratory epithelium and d] an ependymal cyst from the dienceph-
alon [10].
Clinical presentation is heterogenous and may be intermittent, self- resolving
and non-specific. Obstructive hydrocephalus is precipitated by growth of the col-
loid cyst blocking CSF flow through one or both foramen of Monro and may
produce raised intracranial pressure [ICP] by intermittent obstruction of the pas-
sage of CSF at the level of interventricular foramen, acting like a legger of a ball as
historically described by Dandy in 1933 [8].
4.2 Clinical features
Defining the natural history of colloid cyst reliably has been challenging due to
the small number of cases in most case series. Majority of colloid cysts present as an



























Classification of foramen of monro lesions causing obstructive hydrocephalus.
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incidental finding while imaging the brain for unrelated symptoms. Symptoms due
to colloid cyst often result from different forms of hydrocephalus as well as irrita-
tion of major important centers around the third ventricle [11].
They do not have any intrinsic pathological properties and cause symptoms by
acting as inert masses. 90% are asymptomatic and stable, while 10% are found to
increase in size and cause hydrocephalus. Sudden increase in size can lead to drop
attacks, dementia, coma, and death.
Headaches are the most common symptom of colloid cyst ranging from 65–
100% of cases according to literature. The headaches are typically severe and
intense, throbbing or aching in quality and can be bifrontal or generalized in
location and can be precipitated, aggrevated or relieved by head movement or
position changes. With progression in size of the cyst, the headaches become more
frequent and can be accompanied frequently by nausea, vomiting, blurred vision,
Figure 4.
Case of a small colloid cyst presenting with drop attacks [A-D]: A] pre-op CT showing a hyperdense SOL at
foramen of Monro. B] Endoscopic view of the ventricular anatomy and colloid cyst. C] Normal ependyma with
3rd ventricular floor post excision. D] Post op CT showing complete excision of lesion with re-established CSF
flow across foramen of monro.
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gait ataxia, cognitive decline and less frequently by dizziness, tinnitus and
dysautonomic symptoms like abdominal pain, tachycardia, hyperthermia, brady-
cardia and sweating. Other uncommon symptoms include personality changes,
memory disorders, psychiatric disorders and olfactory and gustatory hallucinations.
Rapid deterioration due to acute hydrocephalus can occur in 3–35% of patients with
an associated 5–38% risk of death [11–13].
4.3 Neuroradiology
Due to the different composition and density of contents, which depends on the
quantity of cholesterol and proteins, colloid cysts may have a diverse appearance on
imaging. Cysts with high cholesterol and protein content are hyperdense on plain
CT, hyperintense on T1 and hypointense on T2 weighted images.
Computed Tomography [CT]: On CT, the colloid cyst is typically a well-defined,
round or oval hyperdense mass in the anterior third ventricle at the foramen of
Monro. Precontrast scans show a] hyperdense lesions in approximately 2/3rd cases,
b] isodense in 1/3rd cases and c] rarely can be hypondense or show calcifications.
(Figure 4).
On post contrast CT, colloid cysts usually do not show enhancement. Less
commonly they may show mild to moderate contrast enhancement. In some cases,
thin rim of contrast enhancement may be present which is thought to represent the
cyst capsule [8].
Figure 5.
case of a large colloid cyst presenting with signs of raised ICP A]& B] preoperative Sagittal T1 and Coronal T2
images isodense third ventricular lesion extending into the septum pellucidum. C] preoperative contrast
enhanced axial image D] intraoperative image with whitish colloid material being excised E] & F] post-
operative T1 sagittal and T2 coronal images showing near total excision.
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4.4 Magnetic Resonance Imaging
MRI is the investigation of choice for imaging colloid cysts. On MR imaging,
some lesions may show intracystic fluid levels or central and peripheral components
in the lesions whereas some lesions are homogenous in appearance.
On T1 Sequencing, colloid cyst is homogenously hyperintense in about 50% of
cases while the other lesions can be hyperintense, isointense or hypointense. On T2
Sequence imaging, most colloid cysts are hypointense. Low signal intensity on T2
imaging may correspond to the viscous contents of the colloid cyst and thus harder
to aspirate. Post contrast enhancement of the cyst is not seen usually and rarely a
peripheral enhancement will be noted around the cyst which represents a vessel
stretched over the colloid cyst. (Figure 5)
Colloid cysts usually have a similar intensity to surrounding CSF on FLAIR
sequencing and may have decreased signal intensity on diffusion weighted
imaging [10].
4.5 Treatment
For patients who are symptomatic and have a higher degree of ventricu-
lomegaly, more immediate surgical options include craniotomy for microsurgical
resection, neuroendoscopic removal, and CSF -diversion with ventriculo-peritoneal
[VP] shunts.
The transcallosal microsurgery and endoscopic approach were compared for the
first time by Lewis et al. in 1994. The findings of their comparison were shorter stay
in the hospital and early recovery in the endoscopic approach group [14].
In a study by N.B. Levine et al. from 1991 to 2004, the conclusion was made
that endoscopy approach should be offered to all patients as the first line of
management [15].
Criterion Points
















Colloid cyst risk score.
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In 2016, Beaumont et al. published the Colloid Cyst Risk Score [CCRS], a
method used to stratify the risk of a patient to develop obstructive hydrocephalus
and guide physicians to choose appropriate treatment pathways. Risk of lesion
progression and obstructive hydrocephalus is more with a CCRS ≥4 [13] (Table 2).
In 2016, Suresh Nair et al. published a study which was done from 1980 to 2011,
275 cases were managed by interhemispheric transcallosal approach, twenty-two by
transcortical approach and 8 by endoscopic approach. They concluded that open
microsurgical approach is the gold standard surgical treatment for colloid cyst [16].
Author recommendations: Neuroendoscopic approach can be offered as the first
line treatment for colloid cyst as it can be used for all classic colloid cysts
irrespective of the cyst site.
The entry burr hole should be 1 cm lateral to the usual Kocher’s point to facilitate
endoscopic septostomy. Depending on the intraoperative bleeding, consistency of
the cyst and the extent of resection, the decision to place a post-operative EVD can
be customized, which can be removed after 4–5 days. Rarely, VP shunt might be
needed in these cases.
Case illustrations (Figures 4 and 5).
5. Craniopharyngioma
5.1 Introduction
Craniopharyngioma [CP] is a benign tumor originating from the squamous
epithelial residual cells anywhere along the obscured craniopharyngeal duct from
Rathke’s cleft to the floor of the third ventricle and they constitute 2–4% of intra-
cranial neoplasms [17]. They often present a surgical challenge to the neurosurgeons
because of their central location and proximity to surrounding neural structures
namely the hypothalamus, pituitary gland, the optic apparatus, circle of Willis,
brainstem and temporal lobes.
Pathologically these tumors are classified into two types: adamantinomous CP
[ACP] and papillary CP [PCP]. ACPs are more common than PCPs, are pathologi-
cally distinct, are composed of cystic “motor oil-like” component and solid compo-
nent with frequent calcifications and are more common in pediatric population
while PCPs are more common in the adult population [18].
The most common location of craniopharyngioma is the sellar and suprasellar
region with 95% of the tumors having a suprasellar component. The suprasellar
component of the tumor grows in various directions compressing the surrounding
structures. The anatomical proximity of the tumors to the major CSF pathways may
result in compression of various parts of the ventricular system causing obstructive
hydrocephalus. Obstruction in these cases can be seen at the following levels a]
basal cisterns b] invasion and obstruction of the inlet and outlet of the third ventri-
cle c] foramen of Monro and rarely d] posterior displacement of the brainstem with
occlusion of the Sylvian aqueduct [19].
Kassam et al. classified suprasellar craniopharyngiomas on the basis of relation-
ship of the tumor to the infundibulum and pituitary stalk as observed in the surgical
field on endoscopic viewing which is as follows: I] pre-infundibulum: Its lateral
relation are carotid arteries, below by the diaphragm sella, infundibulum in the
dorsal portion, and displaced chiasm in the roof. II] trans-infundibulum: The rostral
extent of the tumor is bounded by the anterior portion of the hypothalamus. III]
retro-infundibulum: a] Extending into the third ventricle. b] Extending into the
inter-peduncular cistern. It is bounded anteriorly by the stalk and posteriorly by the
mammillary bodies and basilar apex. IV] intra-ventricular and/or optic recess [20].
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Generally Kassam’s type III and type IV tumors present with obstruction at the level
of foramen of Monro.
5.2 Clinical features
Clinical manifestations are related to hypothalamic and pituitary deficiencies,
visual impairment and raised intracranial pressure [17].
Headaches are seen in about 50% of patients which may be due to raised intra-
cranial pressure or due to meningeal irritation from the cystic fluid and can be
associated with nausea and vomiting.
Symptoms of endocrine dysfunction are seen in 52–87% of patients which are
caused by tumor or treatment related lesions to the hypothalamic–pituitary axis that
affect the secretion of growth hormone [GH] in about 75% patients, gonadotropins
[FSH/LH] in about 40% patients and adrenocorticotropic hormone [ACTH] in
about 25% patients. Patients can also present with vasopressin deficiency causing
diabetes insipidus in about 20% of cases.
5.3 Investigations
Evaluation and management of craniopharyngioma requires an interdisciplinary
approach by endocrinologist, neuro-ophthalmologist and neurosurgeon.
5.4 Neuroradiology
Both CT and MRI are helpful for diagnosis of craniopharyngiomas which are
heterogenous tumors with solid, cystic and calcified components.. PCPs are usually
solid tumors with rare cystic transformations and calcifications. Radiological fea-
tures of ACPs can be summarized by the 90% rule i.e. 90% of tumors are predom-
inantly cystic, 90% show more or less prominent calcifications and about 90% take
up contrast in the cyst wall [21].
CT provides details of the sellar anatomy as well as information related to cystic
and solid components of the tumor, local invasion, compression of adjacent struc-
tures and calcifications.
MRI is also useful for the topographic and structural evaluation of craniophar-
yngiomas. These tumors are isointense or hypointense on T1 weighted images,
hypointense or hyperintense on T2 weighted images and show contrast enhance-
ment. This variability in MRI findings are due to varying proportions of solid and
cystic components and presence of cholesterol, keratin, hemorrhage and amount of
calcification.
5.5 Treatment
The choice of the surgery depends on the anatomical location of the tumor. It has
been reported that gross total resection causes more neurological deficits and does
not improve the chances of its recurrence. The Endoscopic approach is not
recommended for very large tumors with solid component, calcifications or vascu-
lar invasion. Kassam’s type I and type II tumors can be approached by endoscopic
transnasal transsphenoidal technique. However for Kassam’s type III and type IV
tumors have to be approached by endoscopic transventricular or transcranial
approaches (Table 3).
The decision regarding the approach to the lesion is guided by the following
factors a] consistency of the lesion b] calcification c] lateral and extraventricular
extension of the tumor.
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Authors recommendations: In the event of endoscopic transventricular approach
for craniophryngiomas, the authors strongly recommend endoscopic septostomy
and post operative EVD placement in all the cases. VP shunt may be required for
permanent CSF drainage depending on the extent of resection. The incidence of
postoperative VP shunt at a later date is relatively more common in craniophar-
yngiomas than colloid cyst. Also Omaya reservoir can be placed post operatively
for intralesional bleomycin in predominantly cystic lesions limited to the third
ventricle, although the authors have a limited experience regarding the same.
In a study by Deopujari et al. from 2000 to 2016 it was stated that suprasellar
craniopharyngiomas with a major cystic component can be best managed by a
combined endoscopic transcranial and transnasal approach [22].
Case illustration (Figure 6).
The toxic radioactive substances like bleomycin, interferon alpha can be given in
craniopharyngiomas with cystic component only to promote sclerosis and fibrosis.
One of the major disadvantages of this approach is that it can produce severe
neurotoxicity and leakage of the sclerosing substance [23].
For cystic craniopharyngiomas radioisotopes can be implanted through an
endoscopic approach. However, there are no standard guidelines for the intra cystic
dosage and the toxicity level of these drugs along with tumor control dosage, all
these makes this therapeutic option difficult to follow [24].
Table 3.
Algorithm for surgical approaches for predominantly third ventricular craniopharygiomas.
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6. Subependymal Giant Cell Astrocytoma [SEGA]
6.1 Introduction
SEGA also known as Subependymal Giant Cell Tumor [SGCT] are clinically
benign [WHO grade 1], slow growing tumors which usually arise in the
periventricular regions in the proximity of the foramen of Monro. They are associ-
ated with tuberous sclerosis complex [TSC], which is a systemic autosomal disease
characterized by Vogt’s clinical triad of mental retardation, seizures and facial
angiofibroma. TSC has a prevalence ranging from 5 to 20% with radiographic
evidence of subependymal nodules which are a precursor of SEGA seen in 90% of
TSC patients [25, 26].
These are histologically benign tumors and do not undergo malignant transfor-
mation. The lesions which are over 10 mm in diameter at the foramen of Monro can
cause obstruction of CSF flow leading to progressive dilatation of the lateral ventri-
cles and raised ICP and cause the clinical manifestations associated with SEGA [25].
6.2 Clinical features
Preoperative diagnosis of SEGA takes into account the age, clinical condition of
the patients and the location of the tumor. In cases where neurocutaneous manifes-
tations of TSC which include mental retardation, seizures and adenoma sebacum
[Vogt’s triad] are present, early diagnosis of TSC is possible. However solitary
Figure 6.
case of craniopharyngioma [Kassam’s type III] presenting with dwarfism and raised ICP A] pre-operative non
contrast axial CT B], C] & D] pre-operative contrast enhanced axial, coronal and sagittal CT images
respectively E] & F] postoperative non contrast axial and sagittal CT image.
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lesions without clinical or radiological features of TSC have also been reported and
these patients almost always present urgently due to raised ICP.
In the early stage, patients can present with insidious onset subtle behavior
changes, cognitive impairment or seizures. Features of raised ICP like headache and
vomiting are present due to increase in size of the lesion causing obstructive
hydrocephalus or due to intratumoural or intraventricular hemorrhage [26, 27].
6.3 Investigations
CT and MRI characteristics in SEGA are usually nonspecific. Patient factors
which include age and location of the lesion are useful indicators in establishing
diagnosis. Although nonspecific, radiological findings show a well circumscribed
lesion at the foramen of Monro which is isodense or slightly hyperdense on CT with
rare thin calcifications, hypointense on T1, hyperintense on T2 with marked
contrast enhancement [26, 28].
6.4 Treatment
SEGAs are considered to be benign lesions and excision of the tumor is consid-
ered to be curative in patients presenting with a single lesion. Surgical treatment is
indicated in cases of symptomatic SEGA or patients presenting with acute increase
Figure 7.
Young male patient with cutaneous manifestations of TSC presented with sudden onset altered sensorium A]
Preoperative CT brain a circumscribed lesion in the right foramen of Monro region with calcification,
hemorrhage and obstructive hydrocephalus B] Preoperative MRI showing heteregenous enhancement with
mixed cystic and solid areas and multi-stage hemorrhages C] Clinical picture showing cutaneous manifestations
of Tuberous Sclerosis Complex D] Follow up CT brain at 2 years showing near total excision of the tumor
except the calcified part with resolution of hydrocephalus.
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in intracranial pressure due to obstructive hydrocephalus [29]. Other alternative
treatment options are Gamma Knife radiosurgery [GKR] or the mechanistic target
of rapamycin [mTOR] inhibitors which can reduce the size of the mass in TSC. GKR
showed promising results for many types of benign brain tumors, including glio-
mas, with a low incidence of side effects [30].
Authors recommendations: In our experience, SEGA’s were operated by open
transcallosal/ transventricular approaches to the lateral ventricle. As these tumors
are generally solid and firm in consistency, they are not amenable to endoscopic
excision.
Case Illustrations (Figures 7–9).
7. Neurocysticerosis
7.1 Introduction
Neurocysticercosis [NCC] occurs when larval stage of the tapeworm Taenia
Solium migrates to the central nervous system. It is the most common helminthic
infestation of the central nervous system and usually manifests as acute seizure,
epilepsy, progressively worsening headache or focal deficit [31].
The cysts reach the ventricular system through the choroid plexus and are more
frequently found in the fourth ventricle. This can be attributed to the gravitational
Figure 8.
20 year old female with cuteneous manifestations of TCS presenting with raised ICPA]& B] preoperative MRI
showing a contrast enhancing solid lesion at the level of right foramen of Monro leading to univentricular [right
lateral ventricle] hydrocephalus. C] & D] endoscopic septostomy was done to deal with the obstructed right
ventricle with endoscopic biopsy which was suggestive of SEGA. E] & F] postoperative imaging showing
septostomy defect. Later patient was managed with m-TOR inhibitors [rapamycin] with progression free
survival over a period of 2 year follow up.
14
Cerebrospinal Fluid
forces which favor migration from supratentorial ventricles or the cysts may
directly enter through the choroid plexus [32].
The locations of intraventricular cysts determine the natural history of the
disease. Ones attached to the ventricular wall involutes and eventually resolve,
while the cysts which are not attached may migrate and block the cerebrospinal
flow causing obstructive hydrocephalus. Hydrocephalus can occur either due to
ventricular obstruction or arachnoiditis. Sites of obstruction include foramen of
Monro, third ventricle, aqueduct of Sylvius and fourth ventricle [32, 33].
7.2 Clinical features
Active intraventricular cysts may remain asymptomatic for years and may
become symptomatic if they obstruct the CSF flow leading to hydrocephalus and
raised ICP. Abrupt obstruction may lead to acute hydrocephalus and present with
features of hydrocephalus which include headache, nausea, vomiting, diplopia,
restlessness, seizures, respiratory changes, bradycardia, hypertension, altered
sensorium and papilledema or may present infrequently with features of Brun’s
syndrome [34].
Death of an intraventricular cyst larva can lead to liberation of antigenic sub-
stances being released into the ventricular system with local reactions causing an
inflammatory response throughout the ventricular system. These patients will pre-
sent with features of raised ICP, meningoencephalitis, focal neurological deficits
and inflammatory reaction detectable in CSF [35].
Figure 9.
Mentally retarded child with neurocutaneous markers of TSC presented with raised ICP Figure A], B] & C]
MRI revealing large solid enhancing lesion with calcifications at the level of Foramen of monro extending into
the lateral ventricle, third ventricle and involving the septum pellucidum causing obstructive hydrocephalus.
D], E]& F] Post- operative image showing near total excision with VP shunt in situ [which was done at a later
date].
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7.3 Investigations
The diagnosis of intraventricular NCC is based on systematic clinical evaluation,
neuroimaging and serology. However the role of serology is limited due to low
sensitivity and specificity. Various serological tests include a] antibody testing with
immunoblot assay using T. solium antigens on serum or CSF samples b] direct
antigen testing of Taenia solium antigen with ELISA using a monoclonal antibody
against Taenia saginata HP10 antigens on CSF or serum samples c] detection of
Taenia solium specific DNA in CSF by polymerase chain reaction [36].
7.4 Neuroradiology
Identification of scolex in a cystic lesion is the pathognomonic radiological
finding in NCC [32, 34, 35]. Non-contrast CT is sensitive for parenchymal and
calcified lesions but is not sensitive for extraparenchymal disease. CT may fail to
demonstrate small cysts that do not deform the ventricles as a] they share the same
density of CSF b] the cyst wall and the scolex are not visible c] the cyst does not
show contrast enhancement.
MRI is the investigation of choice for extraparenchymal NCC as the MRI prop-
erties of the scolex or the cystic fluid differ and inflammation is marked with
hyperintensity signals which allow a reliable diagnosis.
A viable active intraventricular cyst appears as a well defined thin walled cystic
lesion of 10–20 mm in diameter which is hypointense on T1 with a thin rim of
hyperintensity. The scolex is seen as an eccentric rounded or elongated enhancing
mural nodule of 2-4 mm in diameter within the cyst cavity. On T2 weighted
imaging, the contents of the cyst are isointense with the surrounding tissues with an
hyperintense scolex. Contrast enhanced T1 weighted MRI imaging shows contrast
ring enhancement of the cysts with surrounding edema.
7.5 Treatment
Treatment modalities include antiparasitic drugs, surgery and symptomatic
medications. Medical management includes a] corticosteroids for meningitis,
cysticercal encephalitis and angitis b] antiparasitic drugs which include
praziquantel and albendazole [36].
Principles of surgery include treatment of hydrocephalus and removal of cyst.
Modalities of surgical intervention include a] emergency ventriculostomy b] place-
ment of VP shunt c] Neuroendoscopic or microsurgical extirpation of obstructing
cysts.
As these cysts are not densely adherent to the ventricular wall endoscopic
approach is the preferred surgical option. There is usually no enhancement of the
cyst wall but in cases where the cyst wall is enhancing, it is suggestive of either
ependymal inflammation or adherence of cyst wall to the ependyma. Thus, the
decision to approach these lesions endoscopically, in cases of enhancing cyst wall,
should be taken with caution. Psarros et al. in his study made an observation that
despite rupture of the cyst and spillage of contents in the ventricle, ventriculitis was
not seen. Continuous perioperative irrigation with ringers solution helps in
removing the debris and provides clear vision [37].
Authors recommendations: Post operative External ventricular drain [EVD]
should be placed to address the spillage of contents in the ventricle, but however in
our experience we did not find any inflammatory reaction because of the cyst
contents.





TBM, a frequent form of central nervous system tuberculosis is a serious neuro-
logical disease with significant mortality and morbidity. In India, the estimated
mortality due to TBM is approximately 1.5/100,000 population. Neurological com-
plications like cerebral infarctions and hydrocephalus are common and may cause
worsening of prognosis [38].
Hydrocephalus, one of the most common complications of TBM, can occur early
or late in the clinical course and can also be associated with the commencement of
anti-tubercular drugs.
Hydrocephalus in TBM could be either of communicating or obstructive type,
the former being more common. The main cause of hydrocephalus in both types is
by presence of thick basilar exudates in the subarachnoid spaces or the ventricular
pathways [39].
Obstructive hydrocephalus results from block or compression within the fourth
ventricle due to exudates or leptomeningeal scar tissue or obstruction of aqueduct
of Sylvius due to strangulation of brainstem by exudates or subependymal
tuberculoma [40].
Foramen of Monro is anatomically narrowed by the bulk of the choroid plexus
which is susceptible to obstruction due to a] meningeal inflammation leading to
raised CSF protein content rendering the CSF more viscous and compromising CSF
flow b] focal ventriculitis c] exudates/ scarring in the region of foramen of
monro [41].
Figure 10.
12 year female presented with Bruns syndrome [episodic symptoms of raised intracranial pressure]. A], B] &
C] MRI images showing a cystic lesion in the left lateral ventricle obstructing the left foramen of Monro leading
to obstructive hydrocephalus and deviation of the septum pellucidum to the right. D]& E] intraoperative photo
showing the excision of the white cyst wall with complete decompression of the left foramen of Monro. F]
Postoperative image showing complete excision with midline septum pellucidum.
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8.2 Clinical features
Progression of disease in patients with obstructive hydrocephalus in TBM is
generally rapid as compared to those presenting with communicating hydrocepha-
lus [42].
In addition to the primary and constitutional symptoms of tubercular meningi-
tis, obstructive hydrocephalus should be suspected in any patient with TBM
presenting with sudden onset altered sensorium with or without presence of
papilledema or in patients complaining of rapidly progressive headache with or
without blurring of vision.
8.3 Neuroradiology
Contrast enhanced CT and MRI are helpful in diagnosing the complications of
TBM which include presence of hydrocephalus, subependymal seepage,
tuberculomas infarcts, edema, nodular enhancing lesions and basal exudates [40].
8.4 Treatment
Medical management includes: antituberculous therapy, steroids, dehydrating
agents like mannitol and diuretics such as frusemide and acetazolamide to reduce
CSF production [40, 43].
Surgical management includes CSF diversion surgery which can be done con-
ventionally with a VP shunt or neuroendoscopically.
The advantages of neuroendoscopy are:
a. endoscopic septostomy and monroplasty can be done which obviates the need
of biventricular shunt
b. provides biopsy sample for further confirmation of the diagnosis
Figure 11.
A] Intra-operative image showing obstruction at the level of foramen of Monro with ependymal tubercles B]
perforation of the septum followed by dilatation with C] balloon catheter and D] dilating forceps E] post
foraminoplasty restoration of caliber of the foramen of monro with no damage to surrounding structures.
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c. adhesiolysis can be performed at the level of foramen of monro
d. clearance of exudates decreases the bulk of the infection and restores the CSF
flow which in turn reduces the convalescence period
In a study by Chugh et al. [43]. it was concluded that in cases of TBM with
hydrocephalus endoscopic procedures can be offered as the first line of manage-
ment as it provides the added advantage of performing septostomy, monroplasty
and biopsy at the same sitting.
Case Illustration (Figure 11).
9. Pituitary adenoma
9.1 Introduction
Pituitary tumors are a heterogenous group of CNS lesions that are usually benign
and constitute 10–15% of all primary intracranial tumors in adults. They can be
divided on the basis of their size into macradenomas [diameter more than 10 mm]
and microadenomas [size less than 10 mm. Nonfunctioning pituitary adenomas
with diameter exceeding 40 mm are considered as giant adenomas. These
adenomas are rare and frequently invade the suprasellar structures causing mass
effect [44, 45].
Obstructive hydrocephalus due to a pituitary adenoma is rare with very less
literature available, limited to case reports. Hydrocephalus is rarely the presenting
symptom or can occur during the course of the disease.
Various mechanisms of development of hydrocephalus in pituitary adenomas
include: a] due to lesser resistance, most pituitary macroadenomas have cranial and
anterior extension. The tumor grows along the pituitary stalk upwards through the
sellar diaphragm to impinge on the recesses of the third ventricle. In rare cases, the
tumor becomes large enough to obstruct the intraventricular foramen leading to
secondary hydrocephalus. b] some tumors extend along the floor of the third ven-
tricle and obstruct the Sylvian aqueduct causing obstructive hydrocephalus. c]
through obliteration of suprasellar cistern [46].
9.2 Clinical features
Clinical manifestations of giant pituitary adenomas can be secondary to com-
pression of the surrounding structures, pituitary hormone deficiency or hypopitu-
itarism and tumor hypersecretion [44, 46, 47]. Common manifestations of non
functioning pituitary adenomas include headache, visual impairment and visual
field defects. Obstructive hydrocephalus is characterized by symptoms of raised
ICP which include headache, nausea, vomiting, blurring of vision, memory loss,
irritability, personality changes, papilledema, sleep disturbances, gait disturbances,
loss of bladder control and coma. Involvement of the frontal lobes can be associated
with generalized seizures and dementia. Extension of the tumor into the cavernous
sinus can be associated with third, fourth and sixth nerve palsy.
9.3 Investigations
Necessary investigations for diagnosing a pituitary tumor include hormonal
profile, neuroradiology and fundoscopy.
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9.4 Neuroradiology
Contrast enhanced MRI is the investigation of choice for size and location of the
tumor and its relation to surrounding structures [48]. CT can provide additional
information which include identification of bone destruction and confirmation of
suspected intra/parasellar calcifications (Figure 12).
Figure 12.
60 years old male presented with gradual diminution of vision with altered sensorium with A], B]& C]
preoperative scans showing a sellar, suprasellar and right parasellar lesion [pituitary adenoma] with a cystic
lesion superior to the adenoma causing right foramen of Monro obstruction. D] Intraoperative picture during
transnasal transsphenoidal showing complete decompression of the sellar and suprasellar part of the lesion with
the diaphragm Sella herniating in the Sella. E], F] postoperative CT showing decompression of the sellar lesion but
persistence of the cystic lesion in the right lateral ventricle. G] Neuroendoscopic exploration of the right ventricle
shows cystic lesion with xanthochromic fluid with underlying foramen of Monro. H] Post cyst decompression,
foraminoplasty being performed. I] Rest of the lateral ventricle examined for remnants of cyst. Also a septostomy
was performed and Ommaya reservoir placed post operatively. J], K]& L] post operative scan revealing adequate




The goals of surgery include tumor removal, relieving mass effect, improving
visual abnormalities, reducing hormone hypersecretion to normal levels and
preserving pituitary function [44, 46].
The various modalities of treatment include
a] transsphenoidal approach b] transcranial approach c] combined or two stage
approach
In a study by B.K.Ojha et al. it was documented that, a combined trans-
sphenoidal and simultaneous transventricular/endoscopic approach is a safe and
effective option for giant pituitary macroadenomas in which tumor dimensions,
consistency or history of previous surgical treatment were indicative of incomplete




Intraventricular hemorrhage [IVH] are classified as a] primary – involving the
ventricular system and adjacent ventricular lining without associated parenchymal
or subarachnoid hemorrhage which occurs in about 30% of cases. b] secondary-
primary intracerebral hemorrhage [ICH] or subarachnoid hemorrhage [SAH]
extending into the ventricular system which occurs in about 70% of patients and is
an independent predictor of poor outcome [50].
Pathophysiology of obstructive hydrocephalus in IVH is due to the blood clot
blockage in the CSF pathway. Other contributory factors causing hydrocephalus in
these cases include a] release of inflammatory mediators by the blood components
causing a secondary response b] damage to the ependymal cells lining the ventricles
due to inflammation c] fibrosis and scarring of the arachnoid granulations d] com-
plement activation [51].
10.2 Neuroradiology
CT is the investigation of choice for diagnosing IVH with or without ICH as it
allows for rapid diagnosis and prompt management (Figure 13). Blood is easily
identified on CT as a white hyperdense lesion. CT is also useful to identify other
important factors such as edema and hydrocephalus. Pattern and topography of
bleeding can give important clues about the secondary causes of IVH and addition-
ally CT angiography or contrast enhanced CT can be done for the same [52].
MRI is equally effective to identify acute hemorrhage. It is useful to distinguish
between hemorrhage and an ischemic stroke, although it would be a less preferable
investigation in an emergency situation [53].
10.3 Treatment
Goal of treatment is to limit hemorrhagic mass effect, edema, obstructive
hydrocephalus by rapid removal of blood and blood products from the ventricular
system [54]. Modalities of treatment in these cases include a] EVD insertion b] EVD
combined with use of thrombolytics c] Neuroendoscopic aspiration.
Case Illustration (Figure 13).
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Nosocomial infection of the central nervous system are a serious complication of
patients undergoing neurosurgical procedures like craniotomy, placement of inva-
sive neuromonitoring technique, EVD catheters or CSF shunts.
EVD, which is a common procedure for controlling and monitoring raised ICP
secondary to acute occlusive hydrocephalus has an associated major complication of
bacterial colonization of the catheter and subsequent retrograde infection resulting
in encephalitis, ventriculitis, meningitis, brain abscess, subdural empyema or even
sepsis [55].
Ventriculitis, also termed as ependymitis, ventricular empyema, pyocephalus,
ventricular abscess or pyogenic ventriculitis, is the inflammation of the ependymal
lining of the cerebral ventricles. It can be secondary to meningitis, cerebral abscess,
EVD or shunt related, trauma, CSF leak or as a complication of intrathecal
chemotherapy.
Incidence of ventriculitis according to literature ranges from 5–20% and
incidence of ventricular catheter related ventriculitis ranges from 5–45% [56].
Most common pathogens causing ventriculitis are skin flora which include
staphylococcus epidermidis [70%] and staphylococcus aureus [10%]. Other less com-
mon pathogens include gram negative rods [Klebsiella spp., E. Coli, Pseuodomonas
spp], anaerobes and candida spp. [56].
Obstructive hydrocephalus in these cases is due to the obstruction caused by the
exudates, adhesions and septations at the level of foramen of Monro or the
aqueduct.
11.2 Clinical features
Patients can present with headache, nausea and vomiting, fever, altered mental
state, meningism, focal neurological deficits and features of secondary hydroceph-
alus and raised ICP. On local examination over the subcutaneous shunt tubing,
erythema or tenderness can be seen suggestive of infection [57].
11.3 Investigations
Diagnosis of ventriculitis is done by CSF examination and neuroradiology.
Figure 13.





Ultrasound can be performed for neonates by using a high-frequency transducer
through the anterior fontanelle in coronal and sagittal planes. The most common
findings include an irregular and echogenic ependyma, the presence of intraven-
tricular debris and stranding, intraventricular adhesions and septae associated with
ventricular dilatation [58].
Noncontrast CT may be nonspecific which include dependent hyperdense
ventricular debris, univentricular or biventricular hydrocephalus, periventricular
low density and features of underlying abnormality. Contrast enhanced CT
shows homogenous enhancement of the ependymal lining of the ventricles
(Figure 14).
MRI findings are similar to CT, with the ventricular debris hyperintense T1
weighted images and hypointense on T2 weighted images, with high signal on DWI,
reduced ADC value and are seen as fluid levels of high signal intensity on FLAIR
images [57].
11.5 Treatment
On clinical suspicion of nosocomial ventriculitis, empiric antibiotic therapy
should be initiated.
Surgical modalities for ventriculitis include a] intraventricular/intrathecal
antibiotics b] continuous intraventricular irrigation therapy using a closed
drainage system c] neuroendoscopic ventricular lavage with septostomy/
monroplasty [59].
Rational for early surgery in ventriculitis: The rapid development of polydrug-
resistant class of gram-negative bacteria, poor passage of antibiotics in the
intraventricular space after intravenous injection and hampered CSF flow from
ventricles along with infection cause the ventricles to become an enclosed system in
Figure 14
5 year female child presented with A] monoventricular [left lateral ventricle] hydrocephalus post EVD
insertion. B] Intraoperative evidence of exudates causing blockage of left foramen of Monro. C] Intraventricular
exudates were cleared. D] Foraminoplasty done with E] Septostomy. As there was evidence of exudates in the
right lateral ventricle which could be seen from the septostomy, neuroendoscopic lavage was given bilaterally.
EVD was inserted on the left side. F] Immediate postoperative radiology showing bilaterally equal ventricles
with resolving hydrocephalus.
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which infected CSF collects and the low concentration of antibiotics after
intravenous injection is insufficient to kill the bacteria [60].
The endoscope allows seeing the entire cavity of the ventricles and also facilitat-
ing endoscopic lavage and clearance of the infected CSF. The decrease in infective
load increases the effectiveness of the intrathecal antibiotics. Lavage inside the
ventricles with continuous irrigation over a prolonged period has been reported
with favorable outcomes.
Authors recommendations:We are of the opinion that in cases of ventriculitis a
biventricular lavage with removal of ventricular exudates and adhesions is better
than dealing the infection through one ventricle only.
Case Illustration (Figure 14).
12. Central neurocytoma
12.1 Introduction
Central neurocytoma is a rare benign tumor of neuronal differentiation that is
classified as grade II by World Health Organization [WHO]. They comprise about
0.1 to 0.5% of all brain tumor and are typically seen in young adults around the
third decade. They are characteristically located in the supratentorial ventricular
system more commonly involving the foramen of Monro and in lesser frequency in
the third and fourth ventricle [61].
12.2 Clinical features
These patients present with signs and symptoms of raised ICP induced by
obstructive hydrocephalus [61, 62]. Typical clinical symptoms include headache,
nausea, vomiting, seizures, paresthesias, balance problems, decreased conscious-
ness, weakness, memory and visual disturbances. In rare cases, IVH may also occur.
12.3 Neuroradiology
On noncontrast CT, central neurocytoma appears hyperdense with calcifications
seen in around 50% of cases which are usually punctate in nature [62, 63]. Cystic
degeneration, seen usually in larger tumors can lead to heterogenous appearance of
the tumor. CNs have mild to moderate enhancement on contrast enhanced CT. On
MRI, CNs are hypo to isointense on T1, iso to hyperintense on T2, with moderate
contrast enhancement (Figure 15).
12.4 Treatment
Surgical management with gross total resection is the treatment of choice
[62, 64]. Goals of surgery are a] to establish the CSF pathway, determine the
histopathological diagnosis and establish maximal surgical resection with minimum
risk of neurological impairment. Radiotherapy to the tumor bed is debatable and is
indicated in cases with incomplete resection to prevent tumor progression and
recurrence. Stereotactic radiosurgery has also been proved to be effective compared
to radiotherapy in terms of diminishing tumor recurrences and radiation associated
complications in these cases.
In a study by Chun li et al. on 9 cases of central neurocytoma 2 patients died in
the postoperative period. They concluded that the possibility of recurrence of
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central neurocytomas should be considered based on the histologic features, espe-
cially proliferation index [MIB1-LI] [65].
Case Illustration (Figure 15).
13. Functionally isolated ventricles
In some cases, rapid therapeutic drainage of one lateral ventricle particularly
after a low pressure VP shunt, can cause an ipsilateral slit ventricle which function-
ally obstructs the foramen of Monro [66]. This functional obstruction may lead to
dilatation of the contralateral ventricle.
The treatment of choice of functional ventriculomegaly is neuroendoscopic
intervention with septostomy with third ventriculostomy (Figure 16).
Case Illustration (Figure 16).
Figure 15.
30 year male patient presented with features of raised ICP with MRI findings suggestive of a lesion arising from
the septum pellucidum causing obstruction at the level of right foramen of Monro. Endoscopic surgery was
planned to decompress the tumor with biopsy. However owing to intraoperative intratumoral hemorrhage, a
decompressive craniectomy had to be performed and the tumor was decompressed through transcortical route.
Biopsy was suggestive of central neurocytoma [WHO grade 2] with MIB1-Labeling index following which
patient was referred for radiotherapy.
Figure 16.
34 year male, recently shunted for TBM with hydrocephalus was referred with altered sensorium. MRI brain
was suggestive VP shunt in situ in right lateral ventricle and asymmetric dilatation of the left lateral ventricle.
Neuroendoscopy did not reveal any obstruction at the foramen of monro and hence septostomy was done
following which patient improved.
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Subependymomas are rare, benign, indolent tumors of ependymal origin which
comprise of 0.2%–0.7% of all intracranial tumors. They are slow growing neoplasms
frequently seen in middle aged men more commonly in the fourth [50–60%] and
the lateral [30–40%] ventricles. They also have a predilection for the spine and are
seen in the cervical and cervicothoracic region [67, 68].
These tumors are frequently asymptomatic found incidentally on autopsy or on
neuroimaging done for other medical indications.
14.2 Clinical features.
Symptomatic presentation depends on the location and size of the lesion.
According to literature, tumors located at the septum pellucidum and the foramen
of Monro with a size of more than 4 cms were more likely to become symptomatic
with signs of raised ICP. Cases with spontaneous intratumoral hemorrhage have
also been reported causing obstructive hydrocephalus. Despite the benign nature of
the tumor, cases of tumor recurrence and CNS metastasis have also been reported
[69, 70].
14.3 Neuroradiology
Radiological appearance of these tumors can vary depending on their location.
On MRI, these tumors are typically well demarcated nodular lesions typically in the
fourth or lateral ventricle which are hypo to isointense on T1 weighted images,
hyperintense on T2 weighted images with minimum contrast enhancement
[68, 69].
14.4 Treatment
Total surgical resection is the treatment of choice as these tumors are well
demarcated, noninvasive and avascular. Role of postoperative radiation is debatable
and is reserved in cases with subtotal surgical resection or in case of recurrence
[71, 72].
15. Idiopathic Foramen of Monro stenosis
Idiopathic stenosis of foramen of Monro is a rare cause of enlargement of the
lateral ventricles. It can occur due to an absent or stenosed foramen of Monro or
when a membrane occludes a normal sized foramen of Monro. Patients are usually
asymptomatic but can occasionally present with symptoms of raised ICP [71, 73].
Contrast enhanced MRI is the investigation of choice to exclude other causes of
foramen of Monro obstruction and to assess the presence of potential membranes.
In addition Cine-MRI CSF flowmetry is done to display CSF flow dynamics and
velocity and to determine the site of CSF flow obstruction [73].
Neuroendoscopy is the treatment of choice as endosopic fenestration,
foraminoplasty and septostomy can be done safely and effectively with this
technique and spare the patient lifelong cumulative risk of shunt failure [74].
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16. Choroid plexus tumors
16.1 Introduction
Choroid plexus tumors [CPTs] are rare intraventricular papillary tumors derived
from choroid plexus epithelium which account for 0.3%–0.7% of all intracranial
tumors, 2–6% of pediatric brain tumors, 10–20% of brain tumors in children less
than 1 year and less than 1% of all adult intracranial tumors. The spectrum of
choroid plexus tumors include a] WHO grade I choroid plexus papilloma b] WHO
grade II atypical choroid plexus papilloma and c] WHO grade III choroid plexus
carcinoma. Choroid plexus papillomas are more common than choroid plexus
carcinomas in ratio of about 5: 1 [72, 75].
CPTs arise wherever choroid plexus tissue exists; the lateral ventricle being
the most common site [50% of cases] followed by fourth ventricle [40%], third
ventricle [5%] and multiple ventricles [5%] [75, 76].
16.2 Clinical features
CPTs most commonly present with signs of raised ICP and hydrocephalus
[77–79]. Hydrocephalus can result due to overproduction of CSF, IVH, obstruction
of CSF flow or impaired absorption. In addition to symptoms of raised intracranial
pressure, patients may also present with seizures, focal neurological deficits, com-
plications of chronic raised intracranial pressure like CSF rhinorrhea and visual
disorientation, macrocephaly, and gait unsteadiness. Specific clinical symptoms can
also be present according to the location of the tumor. Diencephalic seizures and
bobble head doll syndrome- due to compression of the thalamus, signs of brainstem
compression, cranial nerve palsies and cerebellar dysfunctions- due to posterior
fossa CPTs, endocrine disturbances, precocious puberty, diabetes insipidus or
diencephalic disorders- due to tumor in the third ventricle.
16.3 Neuroradiology
On Non contrast CT [NCCT], these tumors are seen as isodense to hyperdense
intraventricular masses with intense contrast enhancement [72, 80].
MRI is the investigation of choice for these tumors. On MRI, CPTs appear as a
large intraventricular lesion with irregular enhancing margins. They are isointense
to slightly hyperintense on T1 weighted images, slightly hyperintense on T2
weighted images and show significant contrast enhancement.
16.4 Treatment
Maximum surgical resection followed by non-standardized use of adjuvant
chemotherapy and radiotherapy is the treatment of choice for CPTs [75, 81].
17. Management of Foramen of Monro obstruction
17.1 Diagnosis of foramen of Monro obstruction
A detailed clinico-radiological examination is mandatory for diagnosis of fora-
men of Monro obstruction. Clinical manifestations and radiological features of
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various pathologies causing foramen of monro obstruction have already been
discussed earlier in this chapter. Radiological features suggestive of foramen of
monro obstruction include a] univentricular or biventricular hydrocephalus b] non-
visualization of the third ventricle c] obvious pathology seen in the third or lateral
ventricle in the vicinity of the foramen.
17.2 Management
Nonoperative management: nonoperative management of foramen of Monro
obstruction can be contemplated for very few indications like in patients with a
small IVH causing hydrocephalus or in cases of idiopathic foramen of Monro
obstruction with no signs of raised ICP.
17.3 Surgical management
Surgical management of the foramen of Monro obstruction depends on the
pathology causing the obstruction. Approach can be done either by a] open
craniotomy b] neuroendoscopy.
17.4 Open Craniotomy approaches
There are many surgical approaches for approaching tumors of the ventricular
system. The open approach to foramen of Monro lesions depends on whether the
lesion is predominant in the lateral or third ventricle. Microneurosurgical tech-
niques used to reach the frontal horn of the lateral ventricles and foramen of Monro
are a] frontal transcortical approach and b] anterior transcallosal approach [82].
Approach to foramen of monro lesions predominantly in third ventricle can be done
by lamina terminalis approach either through the pterional or subfrontal corridors
(Figure 17).
Figure 17.





Anatomical landmarks important to be recognized while performing
neuroendoscopic approach to the lateral and third ventricle for performing
septostomy and foraminoplasty include: the anterior caudate vein, thalamostriate
vein, septal vein, choroid plexus and foramen of Monro (Figure 18).
18.2 Introduction
With recent advances in endoscopic techniques, neuroendoscopy has become
the first line of management for intraventricular pathologies. Endoscopic approach
to the foramen of Monro can be considered as minimally invasive version of the
open transcortical approach with the added advantage of panoramic view which can
be achieved by angling the scope or using scopes of different viewing angles. With
recent advances in scope instrumentation, bimanual dissection of pathologies has
also become possible. The definitive treatment of the lesion by endoscopic approach
can always be supplemented with septostomy and monroplasty/foraminoplasty.
18.3 Septostomy
Endoscopic septostomy allows to bypass a unilateral foramen of Monro obstruc-
tion creating a CSF circulation between the obstructed ventricle and the opposite
lateral ventricle that communicates with the third ventricle by the normal foramen
of Monro [77]. This communication between both the lateral ventricles converts
them into a single compartment thus allowing both the ventricles to be drained by
one shunt in cases of bilateral foramen of Monro obstruction.
For performing a septostomy, a linear incision is generally taken 5-6cms lateral
to the midline which is more lateral than the incision taken for endoscopic third
ventriculostomy. The use of navigation also helps in deciding the site of the incision.
A semicircular incision may be opted if we are planning to insert an Ommaya
reservoir.
Authors recommendations: The site of septostomy on the septum pellucidum is
generally posterosuperior to the foramen of Monro, posterior to the anterior septal
vein, at the point where the septum appears to be avascular and thinned out. The
Figure 18.
Anatomy of the lateral ventricle.
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probing of the septum with the blunt tip of the bipolar probe also gives the surgeon
an idea of the thickness of septum pellucidum. If tumor biopsy or resection is
planned simultaneously, septostomy should precede the biopsy or resection as
bleeding while dealing with the tumor may obscure the anatomical orientation
making the septostomy difficult (Figure 19).
Intraventricular hemorrhage has been documented as a complication in litera-
ture and the possible reason is injury to the contralateral septal vein during the
septostomy being performed. However, no such experience has been encountered
by the authors.
In a study by Oertel et al. septostomy was performed 5–10 mm posterior to the
interventricular foramen, in the middle of the corpus callosum [CC] and the fornix
[83]. In a study by Hamada et al. perforation of the septum was done between the
anterior and posterior septal vein [78]. In a study by Roth et al. perforation was
done in the anterior septal area, at the level of the interventricular foramen, midway
between the corpus callosum and the fornix [79].
The largest study on the procedure of endoscopic septostomy was done by P.R.
Aldana and their inference was that septostomy is the most adequate surgery for
unilateral obstruction at the interventricular foramen level [84].
19. Endoscopic Foraminoplasty
Endoscopic foraminoplasty at the interventricular foramen level is not very
commonly reported in the literature. It was reported for the first time by Oi et al.
[85]. This procedure establishes back the connection between the lateral and the
third ventricle. It obviates the need of a shunt and avoids its related complications.
For performing foraminoplasty, the incision and entry of the scope is similar to that
of septostomy.
On entry to the ventricle, the foramen of Monro is recognized by choroid plexus
and the thalamostriate and septal veins.
Endoscopic foraminoplasty can be performed by:
a. excision of the offending lesion
b. clearance of the exudates, adhesions or blood products
Figure 19.
A] Septum pelucidum being probed in a avascular area B] post- perforation, dilatation of septostomy with
balloon dilator C] opposite ventricular wall seen through septostomy.
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c. perforation of septations or membranes
d. enlargement with balloon catheter or dilating forceps
Figure 20.
foraminoplasty can be done by A] excision of lesion B] removal of blood products C] removal of exudates D]
removal of adhesions E] dilatation with dilator forceps F] dilatation with balloon catheter.
Table 4.
Algorithm for surgical management of foramen of Monro obstruction.
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As it always carries a risk of recurrent obstruction because of the scarring,
foraminoplasty should be supplemented with a septostomy. The procedure of dila-
tation carries the risk of injury to the septal vein or thalamostriate vein and there
can also be injury to the fornix leading to memory problems. However, in our
experience, we have never encountered vascular injury in any of our cases. In 1
case, injury to the fornix was seen. However, postoperatively, the patient did not
experience any memory problems (Figure 20) (Table 4).
20. Conclusion
Lesions causing foramen of Monro obstruction resulting in hydrocephalus are a
fairly uncommon entity encountered in neurosurgical practice with
craniopharyngioma and colloid cysts being the most common pathology in children
and adults respectively.
Treatment consists of open craniotomy for solid tumors and endoscopic
approaches (transnasal transsphenoidal and cranial) for cystic lesions. Endoscopic
approach is particularly helpful in decreasing the convalescence period and postop-
erative complications and thus, should be offered as a first line of treatment when-
ever suited.
Septostomy should be a part of standard treatment in all the patients having
foramen of Monro obstruction so as to obviate the need of added shunt procedures.
Although small solid lesions less than 2 cms in size can be addressed by endo-
scopic approach, the learning curve required for endoscopic approach to deal with
solid lesions is very steep. Thus, correct patient selection is of utmost importance
for optimal patient outcome.
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